The TFIID complex is a new autoantibody target in systemic sclerosis.

IF 20.3 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2025-06-19 DOI:10.1016/j.ard.2025.05.008

Jean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith, Yves Piette, Marie Vanthuyne, Carole Lacout, Antoine Brochard, Mohammed Tikly, Jonas De Leeuw, Doreen Dillaerts, Tom Dehaemers, Petra De Haes, Jan L Lenaerts, Daniel Blockmans, Neil McHugh, Sarah Tansley, Emeline Vinatier, Frédéric Houssiau, Carolien Bonroy, Ellen De Langhe, Xavier Bossuyt

引用次数: 0

查看原文本刊更多论文

TFIID复合物是系统性硬化症中一种新的自身抗体靶点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.